• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZOLL MANUFACTURING CORPORATION LIFEVEST WCD 4000 SYSTEM; WEARABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZOLL MANUFACTURING CORPORATION LIFEVEST WCD 4000 SYSTEM; WEARABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number LIFEVEST WCD 4000 SYSTEM
Medical Device Problem Code Incorrect Interpretation of Signal (1543)
Health Effect - Clinical Code Arrhythmia (1721)
Date of Event 10/05/2024
Type of Reportable Event Death
Additional Manufacturer Narrative
The monitor has been returned and the evaluation is underway.The device flag data from the last download does not indicate any device malfunction.The electrode belt has not been recovered.The device flag data from the last download does not indicate any device malfunction.
 
Event or Problem Description
A us distributor contacted zoll to report that a patient passed away on (b)(6) 2024 while reportedly wearing the lifevest.The patient received three inappropriate treatments and a non-lifevest defibrillation.The device was started up at 19:32:12 on (b)(6) 2024.At 22:53:09, an arrhythmia was detected.Ecg shows svt @ 150 bpm with motion/tactile artifact and electrode lead falloff.At 22:54:22, the patient received the first inappropriate treatment.Svt contributed to the false detection.Rhythm at the time of treatment was svt @ 150 bpm with motion artifact and electrode lead falloff.Post shock rhythm was svt @ 150 bpm with motion artifact and electrode lead falloff.At 22:54:41, the patient received the non-lifevest defibrillation.The rhythm at the time of the non-lifevest defibrillations was svt @ 150 bpm.Post shock rhythm was svt @ 150 bpm with motion/tactile artifact and electrode lead falloff.At 22:55:52, the patient received the second inappropriate treatment.Svt contributed to the false detection.Rhythm at the time of treatment was svt @ 150 bpm with motion artifact and electrode lead falloff.Post shock rhythm was svt @ 150 bpm with motion artifact and electrode lead falloff.At 22:56:19, the patient received the third inappropriate treatment.Svt contributed to the false detection.Rhythm at the time of treatment was svt @ 160 bpm with motion artifact and electrode lead falloff.Post shock rhythm was svt @ 160 bpm with motion artifact and electrode lead falloff.The electrode belt was disconnected at 22:56:29 on (b)(6) 2024.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIFEVEST WCD 4000 SYSTEM
Common Device Name
WEARABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
ZOLL MANUFACTURING CORPORATION
121 gamma drive
pittsburgh PA 15238
Manufacturer (Section G)
ZOLL MANUFACTURING CORPORATION
121 gamma drive
pittsburgh PA
Manufacturer Contact
zoll mfg corporation
121 gamma drive
pittsburgh, PA 15238
MDR Report Key20612273
Report Number3008642652-2024-10985
Device Sequence Number7854989
Product Code MVK
UDI-Device Identifier00855778005005
UDI-Public(01)00855778005005(11)170928
Combination Product (Y/N)N
Initial Reporter StatePA
PMA/510(K) Number
P010030
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Distributor
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 11/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Model NumberLIFEVEST WCD 4000 SYSTEM
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/29/2024
Initial Report FDA Received Date11/05/2024
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Reuse
Patient Sequence Number1
Outcome Attributed to Adverse Event Death;
Patient SexUnknown
-
-